Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT02476201

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02476201
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02476201. Allocation not applicable; no masking; primary purpose treatment. Start 2016-02 (actual); primary completion 2019-02-13 (actual). Results posted on 2020-08-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)
Acronym
QUARTO_III
Condition
Heart Failure
Intervention (Device)
MPP ON
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02476201
Content hash
1322b84878d23b6471aaf307fd2072212d4720d76867a6506dafc04b2e8404dc